Document is current
Any future updates will be listed below
-
Authors
Pinello, Natalia
Song, Renhua
Lee, Quintin
Calonne, Emilie
Duan, Kun-Long
Wong, Emilie
Tieng, Jessica
Mehravar, Majid
Rong, Bowen
Lan, Fei
Roediger, Ben
Ma, Cheng-Jie
Yuan, Bi-Feng
Rasko, John E. J.
Larance, Mark
Ye, Dan
Fuks, François
Wong, Justin J.-L. https://orcid.org/0000-0002-7038-5079
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (1126306)
National Health and Medical Research Council (1128175)
National Health and Medical Research Council (1128175)
National Health and Medical Research Council (1177305)
National Health and Medical Research Council (1191613)
University of Sydney
Sydney Catalyst
Arrow Bone Marrow Transplant Foundation
Cancer Institute NSW (2018/CDF002)
Cancer Institute NSW (2105/ECF113)
University of Sydney
- License Information
-
More Information
Article History
Received: 6 February 2024
Revised: 27 April 2024
Accepted: 1 May 2024
First Online: 23 May 2024
Declarations
:
: B.R. is a current employee of Novartis Pharma AG. Novartis did not fund the study.
: Not applicable.
: Not applicable.
